Back to Search Start Over

[Primary biliary cholangitis : an update].

Authors :
Vieira Barbosa J
Vionnet J
Sciarra A
Sempoux C
Aubert V
Moradpour D
Fraga Christinet M
Source :
Revue medicale suisse [Rev Med Suisse] 2018 Aug 29; Vol. 14 (616), pp. 1489-1494.
Publication Year :
2018

Abstract

Primary biliary cholangitis (PBC) is an autoimmune liver disease which affects primarily women and is characterized by progressive destruction of small intrahepatic bile ducts. Most common symptoms are fatigue and pruritus. Diagnostic hallmarks are cholestasis and positive antimitochondrial antibodies. The first-line therapy is ursodeoxycholic acid (UDCA), with excellent results when started at an early stage. Nevertheless, 30‑40 % of patients do not achieve a complete biochemical response with UDCA. In these cases, the adjunction of obeticholic acid can be discussed. Fibrates appear to be a promising alternative. Liver transplantation yields excellent outcomes in advanced cases.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêt en relation avec cet article.

Details

Language :
French
ISSN :
1660-9379
Volume :
14
Issue :
616
Database :
MEDLINE
Journal :
Revue medicale suisse
Publication Type :
Academic Journal
Accession number :
30156781